Active Shortage Injection Analgesia/Addiction
Sufentanil Citrate Injection · 1,592 days since initial FDA posting
FDA lists Sufentanil Citrate Injection as Active Shortage (Hikma Pharmaceuticals USA, Inc.).
Availability on file: Unavailable
Sufentanil Citrate Injection: Active Shortage
Unavailable Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Sufentanil Citrate Injection
- Manufacturer
- Hikma Pharmaceuticals USA, Inc.
- Dosage Form
- Injection
- Presentation
- Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-01)
- Package NDC
- 17478-050-01
Status & Timeline
- Status
- Active Shortage
- Availability
- Unavailable
- First Reported
- May 3, 2022
- Last Updated
- Mar 12, 2026
- Therapeutic Category
- Analgesia/Addiction, Pediatric
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Not currently manufactured
Nearby, Other Sufentanil Shortage Records
FDA reason on file: Not currently manufactured. General shortage guidance lives on the tracker hub.